We examined the ability of IgG anti-crotalic PLA 2 to cross-react with Bothrops spp. venoms, from snakes found in the northeast of Argentina. Immunoblotting and ELISA tests showed that IgG anti-crotalic PLA 2 recognize antigens of bothropic venoms. Indirect hemolytic activity tests showed that the quantity of antibodies that neutralized 50% of Crotalus durissus terrificus venom (ED 50 : 2.1 mg IgG anti-crotalic PLA 2 /100 μg of venom) were also able to neutralize venom from other snakes in the following proportion: 34% of B. alternatus, 18% of B. diporus and 12% of B. jararacussu. Likewise, direct PLA2 activity neutralization tests showed a similar cross-neutralization pattern including 56% of B. alternatus, 29% of B. diporus and 30% of B. jararacussu. In addition, in a myotoxic activity neutralization test, measured by plasma activity of creatine kinase, 35% of B. alternatus venom and 26% of B. diporus venom were neutralized, while no neutralization was detected with B. jararacussu venom. This study presents original data concerning cross-reactions between bothropic venoms from Argentina and IgG anti-crotalic PLA 2 . Our results suggest that anti-crotalic PLA 2 antibodies should not be used to neutralize PLA 2 activity of B. alternatus, B. diporus and especially B. jararacussu venoms; nor to enrich commercial antivenoms against these Bothrops species.
INTRODUCTION
The most abundant snake species that inhabit northeastern Argentina are Bothrops diporus (B.d.), Bothrops alternatus (B.a.) and Bothrops jararacussu (B.j.) that belong to the Viperidae family. Crotalus durissus terrificus (C.d.t.) is the only subspecies of the genus Crotalus that is found in this subtropical region of South America (1) . The venoms from these viperids contain phospholipases A 2 (PLA 2 ) that hydrolyze phospholipids at the sn-2 position in a calcium-dependent manner, releasing fatty acids and lysophospholipids (2) . PLA 2 is the main enzyme responsible for signs and symptoms observed in crotalic envenomation, while it is only partially involved in manifestations of bothropic envenomation (3) (4) (5) .
The toxicity of crotalic PLA 2 (C.PLA 2 ) enzyme is potentiated by a small nonenzymatic protein, crotapotin; therefore, both form a well known complex, crotoxin (6, 7) . This lethal toxin exhibits in vivo a potent neuromuscular and myotoxic activity, and induces in vitro indirect hemolysis when red blood cells are in the presence of egg yolk (8, 9) .
In contrast, PLA 2 from Bothrops spp. do not have an elevated lethality, but exhibit myotoxic, edematogenic, anticoagulant and hemolytic (indirect) activities, which in synergistic action with other components of the venom (thrombin-like enzymes, metalloproteases etc.) become a highly lethal secretion (10) (11) (12) .
Snakebites from these species represent a clinical problem in northeastern Argentina and Brazil, and the treatment of choice for victims has been heterologous antiserum administration (13, 14) . Most commercial antisera are produced in equines and whole venoms are employed for immunizations in order to obtain anti-bothropic (ABS) or anti-crotalic serum (ACS). A specific antiserum is indicated when the snake that bitten the patient is identified (13) . However, there are also commercial antisera against venoms from several species of the same genus, or from different genera, in order to increase the neutralization spectrum, thus improving its versatility (15) .
Over a century ago, Brazil (16) observed that ACS was apparently more efficient than ABS in treating B. jararacussu envenomation. More recently, a mixture of ACS and ABS has been reported to be more effective than ABS alone in neutralizing the myotoxic activity of B. jararacussu venom, suggesting that the addition of antibodies against Crotalus toxic components, such as C.PLA 2 , could be valuable in the treatment of the intoxication (17, 18) . Moreover, Beghini et al. (19) In this work, we analyzed the ability of IgG anti-C.PLA 2 to cross-react with components of bothropic venoms, in order to determine the responsibility of these antibodies in the cross-neutralization between ACS and bothropic venoms. A better understanding of cross-reactions may contribute to the development of more versatile antivenoms. 
MATERIALS AND METHODS

Venom and Toxin
Animals
Male Swiss white mice weighing from 20 to 22 g were supplied by the animal facility of the School of Veterinary Science, UNNE. Mice were housed at 25°C on a 12-hourlight/dark cycle and had free access to food and water.
Male New Zealand white rabbits weighing 3 kg were individually housed with free access to food and water.
IgG anti-C.PLA 2 Rabbit polyclonal antibodies were obtained by immunization with 700 μg of PLA 2 per rabbit mixed with a volume of complete Freund's adjuvant. Boosts were administered on day 7, 14 and 28. Serum antibody levels were monitored by gel immunodiffusion Rodrígues JP et In order to determine whether IgG anti-C.PLA 2 was able to cross-react with bothropic venoms, the amount of IgG corresponding to ED 50 (158 μg) was pre-incubated with 7.5 μg of each bothropic venom. Then, the mixtures were added to wells in agaroseegg yolk-sheep erythrocyte gels. The hemolytic halos were measured after 20 hours of incubation at 37°C, and the percentage of cross-neutralization was calculated.
Samples of bothropic venoms incubated with PBS were considered positive controls.
Direct PLA 2 Activity Neutralization PLA 2 activity was assayed by a kinetic method according to Lôbo de Araújo and Radvanyi (22) . The substrate was a solution of egg phosphatidylcholine (0.265%) in 10 mM CaCl 2 , 100 mM NaCl, 100 mM phenol red and 7 mM Triton X-100. PLA 2 activity (as fatty acid liberated per min) was measured as changes of absorbance per minute, using a spectrophotometer UV/Visible CamSpec M330® (UK) (at 30°C, λ:
558 nm). The reaction was started by adding venom (7.5 μg) pre-incubated with IgG 
Myotoxic Activity Neutralization
Creatine kinase (CK) determination was performed in order to detect the maximum liberation in a 24-hour period after venom inoculation (23) . Groups of five mice (CF1, In order to have a histological assessment of myotoxicity, tissue samples of injected muscle were taken and fixed with Bouin's solution for 24 to 48 hours. Thereafter, tissue was dehydrated in a graded alcohol series and embedded in paraffin. Sections of 5-mm thick were stained with hematoxylin and eosin. Control muscle tissue was processed similarly (24) .
Survival Time
Groups of five animals were intramuscularly inoculated with a challenge dose of two Rodrígues
Statistical Analysis
All experiments were repeated at least three times and the results were expressed as the mean ± SD. The significance of differences between means was assessed by ANOVA followed by Tukey's test for multiple comparisons among groups. Values of p < 0.05 were considered significant.
RESULTS
PLA 2 Cross-reactivity
The reactivity determined by ELISA of IgG anti-C.PLA 2 demonstrated that the reactivity of these specific antibodies was restricted to ~14 kDa components, corresponding to PLA 2s from crotalic and bothropic venoms ( Figure   2B ). Absorbencies were read at 490 nm. As expected, the greatest reactivity was seen with C.d.t. since its PLA 2 was used in the immunization. 
Indirect Hemolytic Activity Neutralization
The amount of antibodies that neutralized 50% of 100 μg of C.d.t. venom was 2.1 ± 0.22 mg. Cross-neutralization of bothropic venoms was express as percentage of inhibition of indirect hemolytic activity (Table 1) . 
Direct PLA 2 Activity Neutralization
We analyzed whether the amount of IgG anti-C.PLA 2 that efficiently neutralize direct PLA 2 activity of C.d.t. venom (ED 50 ) was able to neutralize Bothrops venoms. Table 2 shows that B.a. venom was best cross-neutralized, while B.d. and B.j. showed similar low percentage of neutralization when IgG anti-C.PLA 2 was employed. 
Myotoxic Activity Neutralization
To determine the time of the maximum release of CK for each venom, mice were inoculated with sublethal amount of desiccated venoms and CK activity was 
DISCUSSION
The present study was undertaken to assess the cross-reaction of IgG anti-C.PLA 2 against specific bothropic venoms from Argentina, in order to employ it as antivenom or to enrich commercial antisera with these antibodies. In conclusion, our results further reveal that the cross-reactivity detected in PLA 2 of bothropic venoms from Argentina to specific IgG antibodies anti-C.PLA 2 does not present the appropriated pharmacological effect required for a complete neutralization of the PLA 2 activity of whole bothropic venoms.
Thus, other components of bothropic and crotalic venoms must be studied as molecular targets to generate antibodies, either employed alone or enriching commercial antivenoms with IgG anti-C.PLA antibodies.
